Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)
A pioneering clinical study presented at the 2026 European Congress on Obesity (ECO2026) and published in Nature Medicine, reveals compelling ...
